Table II.
Parameters | Control (U/L) | GLB (U/L) | DM (U/L) | DM+GLB (U/L) | DM+GL (U/L) |
---|---|---|---|---|---|
SGOT | 196.00±18.28 | 182.17±12.28 | 223.67±24.26 | 212.17±29.64 | 205.00±18.02 |
SGPT | 69.83±6.82 | 63.83±7.88 | 182.33±20.05b | 115.67±18.56 | 111.83±18.52 |
ALP | 162.33±18.27 | 157.33±17.64 | 837.33±55.49a | 726.50±27.57a | 766.83±87.85a |
Data are expressed as the mean ± standard error of the mean.
P<0.001
P<0.05 vs. control. GLB, glabridin; DM, diabetes mellitus; GL, glibenclamide; SGOT, glutamate oxaloacetate transaminase; SGPT, glutamate pyruvate transaminase; ALP, alkaline phosphatase.